Onclive articles Copyright (c) 2014 Intellisphere, LLC. All rights reserved. http://www.onclive.com/articles Onclive articles Onclive articles en-us Fri, 06 Mar 2015 11:00:09 UTC 5 Onclive articles 144 47 http://www.onclive.com/articles http://www.onclive.com/media/image/35ab4bcc0544887940a968b55494cbb1.jpg <![CDATA[AbbVie Gains Ibrutinib Through Pharmacyclics Acquisition]]>http://www.onclive.com/web-exclusives/AbbVie-Gains-Ibrutinib-Through-Pharmacyclics-AcquisitionOnclive articlesusThu, 05 Mar 2015 18:26:00 UTCOnclive<![CDATA[Carey Offers Views on Evolving Chemotherapy Options—and Beyond—in TNBC]]>http://www.onclive.com/web-exclusives/Carey-Offers-Views-on-Evolving-Chemotherapy-Optionsand-Beyondin-TNBCOnclive articlesusThu, 05 Mar 2015 15:30:00 UTCOnclive<![CDATA[NCI Director Harold Varmus Resigns]]>http://www.onclive.com/web-exclusives/NCI-Director-Harold-Varmus-ResignsOnclive articlesusThu, 05 Mar 2015 03:56:00 UTCOnclive<![CDATA[BMS, Bavarian Nordic Forge Immunotherapy Collaboration]]>http://www.onclive.com/web-exclusives/BMS-Bavarian-Nordic-Forge-Immunotherapy-CollaborationOnclive articlesusThu, 05 Mar 2015 00:27:00 UTCOnclive<![CDATA[FDA Approves Nivolumab for Lung Cancer]]>http://www.onclive.com/web-exclusives/FDA-Approves-Nivolumab-for-NSCLCOnclive articlesusWed, 04 Mar 2015 18:40:00 UTCOnclive<![CDATA[Antonarakis Discusses AR-V7 and Response to Taxanes in mCRPC]]>http://www.onclive.com/web-exclusives/Antonarakis-Discusses-AR-V7-and-Response-to-Taxanes-in-mCRPCOnclive articlesusWed, 04 Mar 2015 15:41:00 UTCOnclive<![CDATA[Dixon Questions Value of Chemoprevention With Tamoxifen]]>http://www.onclive.com/conference-coverage/mbcc-2015/Dixon-Questions-Value-of-Chemoprevention-With-TamoxifenOnclive articlesusTue, 03 Mar 2015 21:03:00 UTCOnclive<![CDATA[The Doctor Will Tweet With You Now: Social Media for Oncologists]]>http://www.onclive.com/conference-coverage/mbcc-2015/The-Doctor-Will-Tweet-With-You-Now-Social-Media-for-OncologistsOnclive articlesusTue, 03 Mar 2015 16:40:00 UTCOnclive<![CDATA[FDA Accepts sBLA for Adjuvant Ipilimumab in Melanoma]]>http://www.onclive.com/web-exclusives/FDA-Accepts-sBLA-for-Adjuvant-Ipilimumab-in-MelanomaOnclive articlesusMon, 02 Mar 2015 22:55:00 UTCOnclive<![CDATA[GSK, Novartis Product Exchange Completed]]>http://www.onclive.com/web-exclusives/GSK-Novartis-Product-Exchange-CompletedOnclive articlesusMon, 02 Mar 2015 19:25:00 UTCOnclive